Related Experiment Video
Updated: Oct 12, 2025

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
The Hidden Link of Exosomes to Head and Neck Cancer
Yong Teng1, Lixia Gao2, Reid Loveless3
1Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.
Abstract:
Head and neck squamous cell carcinoma (HNSCC) represents an aggressive and heterogenous group of cancers whose pathologies remain largely unresolved. Despite recent advances in HNSCC therapeutic strategies, the overall survival of HNSCC patients remains poor and continues to prompt efforts to develop more effective therapies. Exosomes are a subtype of extracellular vesicles secreted by a variety of cells that have begun to spark significant interest in their roles in cancer. As membranous vesicles, spanning from 30-150 nm in diameter, exosomes mediate the transport of various molecules, such as proteins, nucleic acids, and lipids, intercellularly throughout the body. In doing so, exosomes not only act to deliver materials to cancer cells but also as signals that can confer their progression. Accumulating evidence shows the direct correlation between exosomes and the aggressiveness of HNSCC. However, more research is warranted in this field to further our understanding. In this review, we attempt to highlight the tumor-supporting roles and therapeutic potential of exosomes in HNSCC. We introduce first the biogenesis and component features of exosomes, followed by their involvement in HNSCC proliferation and metastasis. We then move on to discuss HNSCC-derived exosomes' influence on the tumor microenvironment and their function in tumor drug resistance. Finally, we explore the promising potential of exosomes as HNSCC biomarkers and therapeutic targets and drug carriers for HNSCC treatments.
Insights
Exosomes, small vesicles carrying molecules, promote head and neck squamous cell carcinoma (HNSCC) progression and drug resistance. Understanding exosome roles offers new therapeutic strategies for HNSCC patients.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Head and neck squamous cell carcinoma (HNSCC) is an aggressive cancer with poor patient survival rates.
- Exosomes, nanoscale extracellular vesicles, are increasingly recognized for their role in intercellular communication and cancer progression.
- Current therapeutic strategies for HNSCC have limited efficacy, necessitating novel treatment approaches.
Purpose of the Study:
- To review the tumor-promoting roles of exosomes in HNSCC.
- To explore the therapeutic potential of exosomes in HNSCC treatment and diagnosis.
- To elucidate the mechanisms by which exosomes influence HNSCC aggressiveness.
Main Methods:
- Literature review of studies on exosome biogenesis, composition, and function in HNSCC.
- Analysis of exosome involvement in HNSCC proliferation, metastasis, and drug resistance.
- Evaluation of exosome-based biomarkers and therapeutic applications in HNSCC.
Main Results:
- Exosomes facilitate HNSCC progression by transferring oncogenic molecules and influencing the tumor microenvironment.
- HNSCC-derived exosomes contribute to tumor drug resistance.
- Exosomes show potential as biomarkers for HNSCC diagnosis and as carriers for targeted drug delivery.
Conclusions:
- Exosomes play a significant role in supporting HNSCC aggressiveness and mediating therapeutic resistance.
- Targeting exosome pathways presents a promising avenue for novel HNSCC treatments.
- Exosomes hold potential as diagnostic biomarkers and drug delivery vehicles for HNSCC.
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment

